Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | HTR2C | P28335 | 2/20 | 0.40 |
| ▸ | HTR2B | P41595 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorene SCHEMBL2050161 | 0.92 | SRD5A2 (0.42) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL28137058 | 0.83 | RAB9A (0.47) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL1315275 | 0.81 | SRD5A2 (0.46) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL29742590 | 0.80 | SRD5A2 (0.55) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL31174575 | 0.80 | SRD5A2 (0.55) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL29436955 | 0.80 | SRD5A2 (0.55) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL1331342 | 0.80 | SRD5A2 (0.55) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL28813138 | 0.78 | SRD5A2 (0.53) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL27547758 | 0.76 | RAB9A (0.42) | SRD5A2MAOAMAPTCYP1A2HTR2C | |
| Fluorene SCHEMBL27768970 | 0.76 | HCAR2 (0.50) | SRD5A2MAPTSLC6A2RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-3044208-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-12-22 | — | — | EP | disclosed |
| EP-3914965-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2021-12-01 | — | — | EP | disclosed |
| CN-113316744-A | Oxime ester photoinitiators with specific aroyl chromophores | 巴斯夫欧洲公司 | 2021-08-27 | — | — | CN | disclosed |
| US-10793555-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2020-10-06 | — | — | US | disclosed |
| WO-2020152120-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2020-07-30 | — | — | WO | disclosed |
| EP-3186226-B1 | OXIME SULFONATE DERIVATIVES | BASF SE (DE) | 2020-06-17 | — | — | EP | disclosed |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2019-06-06 | — | — | US | disclosed |
| US-8507569-B2 | Photoresist compositions | BASF SE (DE) | 2013-08-13 | — | — | US | disclosed |
| WO-2012101245-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2012-08-02 | — | — | WO | disclosed |
| US-20120038996-A1 | PHOTORESIST COMPOSITIONS | BASF SE (DE) | 2012-02-16 | — | — | US | disclosed |
| EP-2411430-A1 | PHOTORESIST COMPOSITION | BASF SE (DE) | 2012-02-01 | — | — | EP | disclosed |
| US-20110151379-A1 | BLACK MATRIX COMPOSITION WITH HIGH LIGHT-SHIELDING AND IMPROVED ADHESION PROPERTIES | LG CHEM, LTD. (KR) | 2011-06-23 | — | — | US | disclosed |
| WO-2010108835-A1 | PHOTORESIST COMPOSITION | BASF SE (DE) | 2010-09-30 | — | — | WO | disclosed |
| US-20050173809-A1 | Wafer-level package and method for production thereof | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2005-08-11 | — | — | US | disclosed |
| EP-0598552-B1 | Cross-linkable polymeric composition | SOLA INT HOLDINGS (AU) | 1999-06-02 | — | — | EP | disclosed |
| US-5502139-A | ACRYLIC ESTERS CONTAINING FLUORENE RINGS, POLYOXYALKYLENE GLYCOL DIACRYLATE OR DIMETHACRYLATE, SULFUR MONOMER, LENSES, VIDEO DISKS | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1996-03-26 | — | — | US | disclosed |
| EP-0598552-A2 | Cross-linkable polymeric composition | SOLA INTERNATIONAL HOLDINGS, LTD. (AU) | 1994-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120038996-A1 | PHOTORESIST COMPOSITIONS | HAAO, CBR3, AKR1B10 | SRD5A2 670/4885MAOA 165/4885MAPT 2903/4885 |
| US-10793555-B2 | Oxime ester photoinitiators | NR2E3, OXER1, CBR3 | SRD5A2 33/4885MAOA 626/4885MAPT 4764/4885 |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | SRD5A2 300/4885MAOA 884/4885MAPT 4085/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | SRD5A2 276/4885MAOA 895/4885MAPT 579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.